GB932874A - Aqueous pharmaceutical compositions comprising theophylline and a solubilizing agenttherefor - Google Patents
Aqueous pharmaceutical compositions comprising theophylline and a solubilizing agentthereforInfo
- Publication number
- GB932874A GB932874A GB1159262A GB1159262A GB932874A GB 932874 A GB932874 A GB 932874A GB 1159262 A GB1159262 A GB 1159262A GB 1159262 A GB1159262 A GB 1159262A GB 932874 A GB932874 A GB 932874A
- Authority
- GB
- United Kingdom
- Prior art keywords
- guaiacol
- pharmaceutical compositions
- aqueous pharmaceutical
- theophylline
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Aqueous pharmaceutical compositions comprise at least about 40% by volume of water having dissolved therein at room temperature more than 0.83 g. of theophylline per 100 ml. water and, as a solubilizing agent and expectorant, guaiacol or a pharmaceutically acceptable water-soluble derivative thereof, e.g. a glycerol guaiacol ether, potassium guaiacol sulphonate or the hemiacetal condensation product of guaiacol and alloxan. Preferred compositions may contain up to about 20% by volume of ethanol and sucrose as a sweetening and additional solubilizing agent. Conventional excipients, e.g. preservatives, flavours and colouring may also be present.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US147436A US3109773A (en) | 1961-10-25 | 1961-10-25 | Bronchodilator expectorant composition containing theophylline and a guaiacol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB932874A true GB932874A (en) | 1963-07-31 |
Family
ID=22521563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1159262A Expired GB932874A (en) | 1961-10-25 | 1962-03-27 | Aqueous pharmaceutical compositions comprising theophylline and a solubilizing agenttherefor |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB932874A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0358951A1 (en) * | 1988-08-12 | 1990-03-21 | BASF Aktiengesellschaft | Powdery hydrophilic formulation of theophylline, and process for preparing it |
-
1962
- 1962-03-27 GB GB1159262A patent/GB932874A/en not_active Expired
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0358951A1 (en) * | 1988-08-12 | 1990-03-21 | BASF Aktiengesellschaft | Powdery hydrophilic formulation of theophylline, and process for preparing it |
| US4950654A (en) * | 1988-08-12 | 1990-08-21 | Basf Aktiengesellschaft | Hydrophilic theophylline powder formulation and its preparation |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE8402551L (en) | CINNAMOYLMORANOLIN DERIVATIVES | |
| GB1405088A (en) | Slow release formulation | |
| JPS51148013A (en) | Stable insulin preparation for nosal administration | |
| GB932874A (en) | Aqueous pharmaceutical compositions comprising theophylline and a solubilizing agenttherefor | |
| IE791995L (en) | Formulation | |
| FI812602L (en) | VINCAMINSACKARINAT | |
| ES394117A1 (en) | Plant extracts | |
| NL138779B (en) | PROCESS FOR PREPARING PHARMACOLOGICAL PREPARATIONS, FORMED PREPARATIONS OBTAINED BY APPLICATION OF THIS PROCEDURE, AS WELL AS PROCEDURE FOR PREPARING PHENOXYISOBUTY ACID DERIVATIVES SUITABLE FOR USE IN THIS PREPARATION. | |
| GB1191313A (en) | Bronchodilator-Expectorant Compositions | |
| GB1259503A (en) | ||
| IT7922548A0 (en) | DERIVATIVES OF 1,5-DIMETHYLBICYCLO(3.2.1.)-OCTANE, PREPARATION OF THESE COMPOUNDS AND THEIR USE AS COMPOUNDS FOR PERFUMES. | |
| NL175382B (en) | PROCESS FOR THE PREPARATION OF ANTIFLOGISTIC, ANALGETIC OR ANTIPYRETICALLY ACTIVE PHARMACEUTICAL PREPARATIONS AND PROCESS FOR THE PREPARATION OF O-ANILINOPHENYLACETAMINE DERIVATIVES SUITABLE FOR USE | |
| GB1141735A (en) | Pharmaceutical anti-tumor composition | |
| GB949400A (en) | Poliomyelitis vaccines | |
| JPS57206609A (en) | Solution for external use | |
| GB1091134A (en) | Pharmaceutical and veterinary compositions comprising a sorbitol acetal | |
| NO740849L (en) | Cyclopentanyl-tetrahydropyranyl-ether derivative for use in the preparation of physiologically active prostaglandins. | |
| FR1495304A (en) | Mixtures of solvents, comprising alcohol diacetone and water for the preparation of concentrated solutions of active agents | |
| GB976096A (en) | Pharmaceutical compositions | |
| IT7826683A0 (en) | MEVALONOLACTONE DERIVATIVES, PROCEDURE FOR THEIR PREPARATION AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS. | |
| GB1279392A (en) | Sugar-free compositions | |
| GB985773A (en) | Improvements in or relating to coated medicinals | |
| GB1110086A (en) | Improvements in pharmaceutical anti-inflammatory compositions | |
| JPS54138122A (en) | Prostaglandin e preparations | |
| Bourgeois | A Koro syndrome in a patient from Charenton: An ethnopsychiatric transposition. |